March 2007
Chemotherapy Resistance Testing Needs to Be Studied, Jefferson Lung Cancer Surgeon Contends
(Published 3-16-2007) A study led by a lung cancer surgeon at Jefferson Medical College suggests that oncologists should take
more advantage of laboratory tests that have the potential to help determine a lung cancer patient’s resistance to chemotherapy
drugs. All too often, patients with non-small-cell lung cancer (NSCLC) are given standard chemotherapy drugs after surgery
in a “hit or miss” fashion, without doctors knowing which drugs might have better chances than others to help treat the tumor.
Steps should be taken to validate such resistance tests in clinical trials.
Jefferson Scientists Find that Drug-Eluting Stents Are Disappointing in Bypass Grafts--Sometimes
(Published 3-23-2007) While drug-eluting stents are effective in keeping open bypassed heart veins that aren’t too diffuse
(filled with cholesterol plaque), a new study by cardiologists at Jefferson Medical College shows that they fare less well
in keeping open bypassed veins with longer blockages. The researchers suggest that doctors think twice before inserting the
drug-coated stents in such extensively diseased bypassed grafts.
Saki Santorelli, Ed.D., MA, Mindfulness Meditation Teacher and Author, to Present a Special One Day Workshop
(Published 3-26-2007) Saki Santorelli, Ed.D., M.A., the nationally acclaimed leader in bringing Mindfulness Meditation into
western healthcare and society, will present
“A Day of Mindfulness—Meeting Yourself, Meeting the Other,” a full-day workshop on Saturday, May 19.
Volunteers Needed for National Study Examining HIV Treatments
(Published 3-27-2007) Researchers at Thomas Jefferson University are participating in a study designed to compare the differences
in responses by HIV-positive women and men to an HIV medication. Thomas Jefferson University is one of 50 clinical centers
in the United States to participate.
Jefferson Scientists in Nationwide Trial to Study Creatine for Parkinson’s Disease
(Published 3-28-2007) Thomas Jefferson University Hospital in Philadelphia has been named one of 51 medical centers in the
United States and Canada to participate in a large-scale, National Institutes of Health (NIH)-supported clinical trial to
learn if the nutritional supplement creatine can slow the progression of Parkinson’s disease (PD).